Cabenuva is a complete long-acting injectable regimen for HIV-1 treatment.
It combines cabotegravir, an integrase strand transfer inhibitor (INSTI), and rilpivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI).
The intramuscular injections are administered once monthly or every two months, replacing daily oral ART in eligible patients.
Cabenuva is a complete long-acting injectable regimen for HIV-1 treatment.
It combines cabotegravir, an integrase strand transfer inhibitor (INSTI), and rilpivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI).
The intramuscular injections are administered once monthly or every two months, replacing daily oral ART in eligible patients.
Image 1 of 2
Image 2 of 2